Lucida Medical’s new brand identity

Lucida Medical has changed its brand identity to strengthen its position as a trusted leader in prostate cancer diagnostics. The updated brand identity reflects the company’s commitment to innovation, precision, and progress, qualities that define both its technology and mission.

Inspired by “Lucida,” the brightest star in a constellation, and the North Star, long used for navigation, the company serves as a guiding light, bringing clarity and confidence to MRI interpretation for prostate cancer care.

This guiding role has never been more critical as MRI reshapes prostate cancer management but depends on increasingly scarce expert resources. With 1.5 million new cases diagnosed globally each year, healthcare systems need solutions that deliver expert-level performance at scale. Pi™ addresses this challenge by automating MRI analysis with clinically validated results: 95% sensitivity and 67% specificity, matching the performance of expert prostate radiologists.

By optimizing workflows and enhancing diagnostic precision, Lucida Medical empowers healthcare providers to improve patient outcomes, streamline care pathways, and elevate the standard of prostate cancer management at every stage, from screening to treatment planning.

This brand evolution represents Lucida Medical’s continued commitment to advancing medical imaging, AI applications, and cancer diagnostics. As the company refines its technology and expands its impact through clinical partnerships worldwide, it remains dedicated to perfecting the prostate cancer pathway.